Women diagnosed with breast cancer may benefit from having the molecular subtype of different cells within their tumors identified, argue researchers. While breast cancer is often treated as a whole, they discuss the growing consensus that cancer cells within a tumor can have multiple origins and respond variably to treatment. The authors advocate for more accurate diagnostic tests to capture molecular irregularities between tumor cells.